Beating earnings estimates typically has a positive impact on investor sentiment and can lead to a short-term increase in stock price. Mira Pharmaceuticals' better-than-expected loss per share indicates operational efficiency or cost management that was above analyst expectations, which could positively influence the stock's performance in the short term.